GO:0003756 protein disulfide isomerase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0003756 defines protein disulfide isomerase activity, the catalysis of intrachain and interchain disulfide bond rearrangement in proteins.
• PDI enzymes are thiol-disulfide oxidoreductases that shuffle disulfide bonds to ensure correct protein folding and function.
• PDI activity is critical for thrombus formation, cancer progression, and vascular diseases [1,3,5,6,7].
• Key genes include P4HB (PDIA1), PDIA3, PDIA4, PDIA6, and other PDI family members [1,8].
• PDI inhibitors are being explored as therapeutic agents in thrombosis and cancer [5,7].
• CRISPR knockout, knock-in, and overexpression models enable functional dissection of PDI genes in disease contexts [4,8].
Description
Protein disulfide isomerase (PDI) activity, encoded by GO:0003756, is a fundamental molecular function that catalyzes the rearrangement of both intrachain and interchain disulfide bonds in proteins. This activity is essential for proper protein folding in the endoplasmic reticulum and for redox signaling in various cellular compartments [1,6]. PDI enzymes are characterized by the presence of thioredoxin-like domains containing a CXXC active-site motif that mediates thiol-disulfide exchange reactions. Beyond protein folding, PDI activity has emerged as a critical regulator of thrombosis, cancer, and vascular diseases [1,3,5,6,7]. For researchers, understanding PDI activity provides insights into redox biology, protein quality control, and potential therapeutic targets. The ability to manipulate PDI genes using CRISPR-based approaches has accelerated functional studies and drug discovery efforts [4,8].
protein disulfide isomerase activity At A Glance
| GO ID | GO:0003756 |
|---|---|
| GO term | protein disulfide isomerase activity |
| Ontology | molecular_function |
| Synonym | disulphide bond formation, protein cysteine-thiol oxidation, protein disulfide-isomerase, protein disulphide isomerase activity, protein thiol-disulfide exchange, protein thiol-disulphide exchange, S-S rearrangase activity |
| Major function | Catalysis of rearrangement of intrachain and interchain disulfide bonds in proteins |
| EC number | 5.3.4.1 |
| Reactome pathway | Protein folding and maturation |
| Related genes | P4HB, PDIA3, PDIA4, PDIA6, PDIA2, PDIA5, PDIA6, TXNDC5, ERP27, ERP29, ERP44, TMX1, TMX3, TMX4, AGR2, AGR3, CASQ1, CASQ2 |
What Is GO:0003756?
Protein disulfide isomerase activity (GO:0003756) is defined as the catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins. This activity involves the exchange of thiol and disulfide groups, enabling proteins to correct non-native disulfide bonds and achieve their properly folded, functional conformations. The reaction is mediated by enzymes containing thioredoxin-like domains with a conserved CXXC active site.
Why Is protein disulfide isomerase activity Important in Cell Biology?
Protein disulfide isomerase activity is essential for maintaining proteostasis and redox homeostasis in eukaryotic cells [1,6]. Dysregulation of PDI activity contributes to thrombotic disorders, cancer progression, and vascular diseases, making it a promising therapeutic target [1,3,5,6,7]. PDI enzymes also play roles in pathogen virulence, such as in Aspergillus fumigatus conidial hydrophobicity, and in vitamin K epoxide reductase activity. Understanding PDI function at the molecular level is critical for developing inhibitors and modulators for clinical applications [5,7].
• PDI activity is required for proper protein folding and quality control in the endoplasmic reticulum.
• PDI enzymes regulate thrombus formation by mediating disulfide bond rearrangement on platelet surface proteins [1,3].
• PDI inhibition is a promising strategy for antithrombotic therapy.
• PDI overexpression enhances vitamin K epoxide reductase activity, linking it to coagulation.
• PDI activity modulates NADPH oxidase and vascular redox signaling.
• PDI family members are implicated in cancer progression and immune evasion [5,8].
• PDI enzymes contribute to fungal virulence and conidial hydrophobicity.
• PDI inhibitors are being developed as anticancer agents.
• PDI activity is a biomarker for cancer prognosis and immunotherapy response.
• CRISPR-based models enable precise dissection of PDI gene functions in disease [4,8].
Mechanism, Genes and Research Methods of protein disulfide isomerase activity
What Happens During protein disulfide isomerase activity?
In simple terms: PDI enzymes act like molecular editors that fix incorrect disulfide bonds in proteins.
Protein disulfide isomerase activity catalyzes the rearrangement of disulfide bonds through thiol-disulfide exchange reactions. The enzyme first reduces a non-native disulfide bond, forming a mixed disulfide intermediate with the substrate, then resolves this intermediate to form the correct disulfide bond. This process can also introduce new disulfide bonds or reduce existing ones, depending on the redox environment. The activity is essential for the folding of secretory and membrane proteins in the endoplasmic reticulum.
Structural Basis of PDI Activity
In simple terms: PDI proteins have a modular structure with active sites that can swap disulfide bonds.
PDI enzymes typically contain multiple thioredoxin-like domains, including catalytically active a and a' domains with CXXC motifs, and non-catalytic b and b' domains that provide substrate binding. The active-site cysteines undergo reversible oxidation-reduction to mediate disulfide exchange. The b' domain is critical for substrate recognition and binding, while the a and a' domains catalyze the thiol-disulfide exchange reactions.
Substrate Recognition and Catalytic Cycle
In simple terms: PDI binds to misfolded proteins and reshuffles their disulfide bonds until they are correct.
PDI binds to exposed hydrophobic regions of substrate proteins through its b' domain, facilitating access to disulfide bonds. The catalytic cycle involves nucleophilic attack by the active-site cysteine thiolate on a substrate disulfide, forming a mixed disulfide intermediate, followed by resolution to either reduced or oxidized product. The redox state of the active site is modulated by the cellular environment and interacting partners such as ER oxidoreductin 1 (Ero1).
Cofactors and Regulation
In simple terms: PDI activity is influenced by redox conditions and interacting proteins.
PDI activity is regulated by the redox balance of the endoplasmic reticulum, with oxidizing conditions favoring disulfide bond formation and reducing conditions favoring reduction. Ero1 reoxidizes PDI to maintain its catalytic activity. Additionally, PDI can be regulated by post-translational modifications such as S-nitrosylation and by interactions with other redox proteins. In thrombosis, PDI is secreted and associates with the platelet surface, where it modulates integrin function [1,3].
Key Genes Involved in GO:0003756 protein disulfide isomerase activity
The following genes encode proteins with protein disulfide isomerase activity or related functions, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| P4HB (PDIA1) | Major PDI in the ER; catalyzes disulfide bond formation and rearrangement | Thrombosis, cancer, vascular disease [1,3,5,6,7] |
| PDIA3 | ERp57; involved in glycoprotein folding and MHC class I assembly | Cancer prognosis and immunotherapy response |
| PDIA4 | ERp72; PDI family member with chaperone activity | Protein folding and ER stress |
| PDIA6 | Inhibits IRE1α signaling; regulates unfolded protein response | ER stress and apoptosis |
| PDIA2 | Pancreas-specific PDI; involved in proinsulin folding | Diabetes and pancreatic function |
| PDIA5 | ER PDI family member; role in integrin maturation | Cell adhesion and migration |
| TXNDC5 | Thioredoxin domain-containing protein 5; PDI-like activity | Cancer and fibrosis |
| ERP27 | ER protein 27; PDI family member | Protein folding |
| ERP29 | ER protein 29; involved in secretory protein folding | Cancer and ER stress |
| ERP44 | ER protein 44; regulates ER redox and calcium homeostasis | Vascular disease |
| TMX1 | Thioredoxin-related transmembrane protein 1; regulates platelet function | Thrombosis |
| TMX3 | Thioredoxin-related transmembrane protein 3; PDI-like | Protein folding |
| TMX4 | Thioredoxin-related transmembrane protein 4; PDI-like | ER redox regulation |
| AGR2 | Anterior gradient 2; PDI-like activity in mucus production | Cancer and inflammation |
| AGR3 | Anterior gradient 3; PDI-like | Cancer |
| CASQ1 | Calsequestrin 1; calcium-binding protein with PDI-like domain | Muscle function |
| CASQ2 | Calsequestrin 2; calcium-binding protein with PDI-like domain | Cardiac function |
How Is protein disulfide isomerase activity Regulated?
Protein disulfide isomerase activity is regulated at multiple levels. The redox environment of the endoplasmic reticulum, maintained by Ero1 and glutathione, controls the oxidative state of PDI active sites. Post-translational modifications, including S-nitrosylation and phosphorylation, modulate PDI activity. In thrombosis, PDI is secreted from platelets and endothelial cells and associates with the cell surface, where it is regulated by redox conditions and interacting proteins [1,3]. Additionally, PDI expression is induced by ER stress through the unfolded protein response.
protein disulfide isomerase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| P4HB | Thrombosis, cancer, vascular disease | Knockout mice, platelet-specific KO, overexpression cell lines [1,3,5,6,7] |
| PDIA3 | Cancer prognosis and immunotherapy response | Knockout cancer cell lines, xenograft models |
| PDIA6 | ER stress and apoptosis | Knockout cell lines, ER stress inducers |
| PDI1 (Aspergillus) | Fungal virulence | Knockout Aspergillus strains, infection models |
| VKORC1 | Vitamin K cycle and coagulation | Overexpression of PDI with VKORC1 in cell lines |
Protein Disulfide Isomerase in Thrombosis
PDI plays a critical role in thrombus formation by mediating disulfide bond rearrangement on platelet surface proteins, including integrin αIIbβ3 and tissue factor [1,3]. Inhibition of PDI activity reduces thrombus formation in animal models, making PDI a promising antithrombotic target. PDI is secreted from activated platelets and endothelial cells, and its activity is required for fibrin generation and platelet aggregation [1,3].
PDI in Cancer
PDI family members are overexpressed in various cancers and contribute to tumor progression, metastasis, and chemoresistance [5,8]. PDIA3 is a robust prognostic biomarker for cancers and predicts immunotherapy response. PDI inhibitors are being developed as anticancer agents, with several showing efficacy in preclinical models.
PDI in Vascular Diseases
PDI regulates NADPH oxidase activity and reactive oxygen species production in vascular cells, implicating it in hypertension and atherosclerosis. PDI also modulates vascular remodeling and endothelial function. Targeting PDI activity may offer therapeutic benefits in vascular diseases.
PDI in Infectious Diseases
In Aspergillus fumigatus, PDI1 is required for RodA assembling-based conidial hydrophobicity, a key virulence factor. This highlights PDI as a potential antifungal target.
From protein disulfide isomerase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does P4HB knockout affect thrombus formation? | Platelet-specific P4HB knockout mice [1,3] |
| Does PDIA3 knockout alter cancer immunotherapy response? | PDIA3 knockout cancer cell lines and syngeneic mouse models |
| Does PDI overexpression enhance VKORC1 activity? | P4HB overexpression in HEK293 or HepG2 cells |
| Does PDI inhibition reduce fungal virulence? | PDI1 knockout Aspergillus fumigatus |
| Does point mutation in PDI active site abolish activity? | CRISPR knock-in of CXXC to AXXA in P4HB |
| Does PDI regulate NADPH oxidase? | P4HB knockout vascular smooth muscle cells |
How to Study the protein disulfide isomerase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Insulin reduction assay | PDI-mediated reduction of insulin disulfide bonds | Enzyme kinetics and inhibitor screening [1,5] |
| RNase A refolding assay | PDI chaperone and isomerase activity | Characterization of PDI mutants |
| Redox proteomics | Disulfide bond status of proteins | Identification of PDI substrates |
| CRISPR knockout screens | Gene essentiality and drug sensitivity | Discovery of PDI pathway modulators |
| Platelet aggregation assay | Platelet function and thrombus formation | Evaluation of PDI inhibitors in thrombosis [1,3] |
| ERroGFP imaging | ER redox state | Live-cell monitoring of PDI activity |
| Mass spectrometry | Disulfide bond mapping | Structural analysis of PDI substrates |
| qPCR/Western blot | PDI gene and protein expression | Validation of knockout or overexpression [4,8] |
Biochemical Assays for PDI Activity
PDI activity is commonly measured using insulin reduction assays, which monitor the reduction of insulin disulfide bonds by PDI in the presence of DTT. Other methods include the RNase A refolding assay and fluorescent probes such as di-eosin-GSSG. These assays are used to screen for PDI inhibitors and to characterize mutant enzymes [5,7].
Proteomic Approaches
Proteomic methods such as redox proteomics and disulfide bond mapping by mass spectrometry can identify PDI substrates and monitor disulfide bond rearrangement. These techniques are valuable for understanding PDI substrate specificity and for discovering new PDI targets.
CRISPR Screening
Genome-wide CRISPR knockout screens can identify genes that modulate PDI activity or sensitivity to PDI inhibitors. Such screens have revealed synthetic lethal interactions and resistance mechanisms.
Imaging and Cellular Assays
Fluorescent reporters of ER redox state and disulfide bond formation, such as ERroGFP, enable live-cell imaging of PDI activity. Platelet aggregation and fibrin generation assays are used to study PDI function in thrombosis [1,3].
How CRISPR Can Be Used to Study GO:0003756 protein disulfide isomerase activity
Knockout
CRISPR knockout of PDI genes such as P4HB or PDIA3 enables loss-of-function studies to determine their roles in thrombosis, cancer, and protein folding [1,5,8]. Knockout cell lines and mouse models are used to assess the impact on disulfide bond formation and disease phenotypes [1,3].
Point Mutation
CRISPR-mediated point mutations can be introduced into the active-site CXXC motif of PDI genes to abolish catalytic activity while preserving protein structure. Such models help distinguish between catalytic and chaperone functions of PDI.
Knock-in
Knock-in of tagged PDI alleles (e.g., HA or FLAG) allows for affinity purification and proteomic identification of PDI substrates and interacting partners. Knock-in of disease-associated mutations can model human disorders.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of PDI genes can enhance PDI activity to study its effects on protein folding, vitamin K epoxide reductase activity, and thrombosis [4,6]. Overexpression models are useful for gain-of-function studies.
How EDITGENE Supports protein disulfide isomerase activity Research
Researchers studying protein disulfide isomerase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. EDITGENE provides comprehensive CRISPR-based services to enable precise genetic manipulation and functional validation.
Contact EDITGENE today to design your custom CRISPR model for protein disulfide isomerase activity research.
Frequently Asked Questions About protein disulfide isomerase activity
What is protein disulfide isomerase activity?
Protein disulfide isomerase activity (GO:0003756) is the catalysis of the rearrangement of both intrachain and interchain disulfide bonds in proteins, a critical step in protein folding.
What genes are involved in protein disulfide isomerase activity?
Key genes include P4HB (PDIA1), PDIA3, PDIA4, PDIA6, PDIA2, PDIA5, TXNDC5, ERP27, ERP29, ERP44, TMX1, TMX3, TMX4, AGR2, AGR3, CASQ1, and CASQ2 [1,8].
How is protein disulfide isomerase activity measured?
It is commonly measured using insulin reduction assays, RNase A refolding assays, and fluorescent probes such as di-eosin-GSSG.
What diseases are associated with protein disulfide isomerase activity?
It is associated with thrombosis, cancer, vascular diseases, and fungal infections [1,2,3,5,6,7,8].
Can CRISPR be used to study protein disulfide isomerase activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable functional studies of PDI genes [1,4,5,8].
What are PDI inhibitors?
PDI inhibitors are small molecules that block PDI activity and are being developed for antithrombotic and anticancer therapy [5,7].
How does PDI contribute to thrombosis?
PDI mediates disulfide bond rearrangement on platelet surface proteins, promoting platelet aggregation and fibrin formation [1,3].
Is PDI a good cancer target?
PDI family members are overexpressed in cancers and contribute to progression and chemoresistance, making them attractive targets [5,8].
What is the role of PDIA3 in cancer?
PDIA3 is a prognostic biomarker for cancers and predicts immunotherapy response.
How does PDI regulate NADPH oxidase?
PDI regulates NADPH oxidase activity and reactive oxygen species production in vascular cells.
Conclusion
Protein disulfide isomerase activity (GO:0003756) is a fundamental molecular function that governs protein folding and redox signaling. Its roles in thrombosis, cancer, and vascular diseases make it a high-value target for therapeutic development. CRISPR-based models and EDITGENE services provide powerful tools to dissect PDI gene functions and accelerate drug discovery.
References
- 1. Chiu J et al.. 2015. Protein Disulfide Isomerase in Thrombosis.. Semin Thromb Hemost 41(7):765-73 PMID: 26408919
- 2. Hu X et al.. 2024. Protein disulfide isomerase 1 is required for RodA assembling-based conidial hydrophobicity of Aspergillus fumigatus.. Appl Environ Microbiol 90(4):e0126023 PMID: 38501925
- 3. Banerjee M et al.. 2016. How Does Protein Disulfide Isomerase Get Into a Thrombus?. Arterioscler Thromb Vasc Biol 36(6):1056-7 PMID: 27225788
- 4. Chetot T et al.. 2022. Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.. Biochem Cell Biol 100(2):152-161 PMID: 35007172
- 5. Nie Q et al.. 2025. The Role of Protein Disulfide Isomerase Inhibitors in Cancer Therapy.. ChemMedChem 20(1):e202400590 PMID: 39319369
- 6. Laurindo FR et al.. 2008. Novel role of protein disulfide isomerase in the regulation of NADPH oxidase activity: pathophysiological implications in vascular diseases.. Antioxid Redox Signal 10(6):1101-13 PMID: 18373437
- 7. Flaumenhaft R et al.. 2015. Therapeutic implications of protein disulfide isomerase inhibition in thrombotic disease.. Arterioscler Thromb Vasc Biol 35(1):16-23 PMID: 25104801
- 8. Tu Z et al.. 2022. Protein Disulfide-Isomerase A3 Is a Robust Prognostic Biomarker for Cancers and Predicts the Immunotherapy Response Effectively.. Front Immunol 13:837512 PMID: 35401558
